SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

HC Wainwright & Co. Reiterates Buy on Taro Pharmaceutical Indus, Raises Price Target to $96

HC Wainwright & Co. reiterates Taro Pharmaceutical Indus (NYSE:TARO) with a Buy and raises the price target from $94 to $96.

Benzinga · 05/21/2020 11:09

HC Wainwright & Co. reiterates Taro Pharmaceutical Indus (NYSE:TARO) with a Buy and raises the price target from $94 to $96.